Organized by the Institute for Global Health Barcelona (ISGlobal), this workshop’s objective is to discuss the advances in antiparasitic treatment and care in people with Chagas disease.
Presentations
Time: 11:30-12:10
| Resultados del estudio BENDITA (Estudio Fase II con distintos esquemas terapeúticos de Benznidazol solo o combinado con pro-ravuconazol) Fabiana Barreira, Chagas Senior Clinical Manager, DNDi, Rio de Janeiro, Brasil |
Time: 12.50- 13.30
| Resultados del primer ensayo clínico con Fexinidazol en pacientes con enfermedad de Chagas Isabela Ribeiro, Head of Dynamic Portfolio Unit, DNDi |
More information:
